Belgium, Gosselies
... RNA, or for vaccine purposes. We have also developed an innovative and patented technology (Staby®) for the antibiotic-free bioproduction of plasmids and recombinant proteins in E. coli cells. Our technology significantly increases the stability of plasmid DNA in host strains, resulting in an overall improvement in production yield and reproducibility. It serves as a good alternative to standard antibiotic resistance genes and meets regulatory demands. Please feel free to contact us for more information!

The europages app is here!

Use our improved supplier search or create inquiries on the go with the new europages app.

Download in the App Store

App StoreGoogle Play